Robert Mentz and C. Michael Gibson discuss the latest trial to address whether iron supplementation, this time with ferric carboxymaltose, improves outcomes for patients with HF and iron deficiency.

In the Swedish survey, many patients said their sexual health was impaired, but few got the information they wanted.

The accuracy of a several popular consumer smart devices for detecting atrial fibrillation (AF) did not improve over a ...

Two studies presented at AHA show the capacity of AI to improve sonographer accuracy, consistency, and workflow.

One is an siRNA biologic, the other an oral agent, but both lowered Lp(a) levels by 80% or more in ASCVD patients.

Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.

In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...

The mixed, counterintuitive results hinder trial interpretation, but along with ARREST-AF, experts still see actionable ...

A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...

The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.

Part 2 of this 7,000-patient trial suffered from discontinuations and low event rates: still, early MRAs did not impact CV ...

Low event rates and short TTRs with warfarin were notable, and questions persist as to which patients truly need OAC.